persmedРоссийский журнал персонализированной медициныRussian Journal for Personalized Medicine2782-38062782-3814ФОНД АЛМАЗОВА10.18705/2782-3806-2022-2-2-46-53persmed-16Research ArticleОБЗОРЫREVIEWERSСиндром обструктивного апноэ сна и сердечно-сосудистые заболевания: от диагностики к персонализированной терапии (часть 1)Obstructive sleep apnea syndrome and cardiovascular diseases: from diagnosis to personalized therapy (part 1)https://orcid.org/0000-0001-7293-1144ИонинВ. А.IoninV. A.

Валерий Александрович Ионин, к. м. н., доцент, старший научный сотрудник

Федеральное государственное бюджетное образовательное учреждение высшего образования «Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова»

кафедра терапии факультетской с курсом эндокринологии,кардиологии с клиникой им. акад. Г. Ф. Ланга

тел.: +79213727684

Санкт-Петербург

Valery A. Ionin, PhD, Associate Professor, Senior Researcher Federal State Budgetary Educational Institution of Higher Education "First St. Petersburg State Medical University named after Academician I. P. Pavlov"

Department of faculty therapy with a course of endocrinology,cardiology with a clinic named after acad. G. F. Lang

phone: +79213727684

Saint-Petersburg

ionin.v.a@gmail.comhttps://orcid.org/0000-0002-8479-0331ПавловаВ. А.PavlovaV. A.

Виктория Александровна Павлова, клинический ординатор

Федеральное государственное бюджетное образовательное учреждение высшего образования «Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова»

кафедра терапии факультетской с курсом эндокринологии, кардиологии с клиникой им. акад. Г. Ф. Ланга

Санкт-Петербург

Victoria A. Pavlova, Clinical Resident

Federal State Budgetary Educational Institution of Higher Education "First St. Petersburg State Medical University named after Academician I. P. Pavlov"

Department of faculty therapy with a course of endocrinology, cardiology with a clinic named after acad. G. F. Lang

Saint-Petersburg

ilingina@mail.ruhttps://orcid.org/0000-0002-8788-0076БарановаЕ. И.BaranovaE. I.

Елена Ивановна Баранова, д. м. н., профессор, , директор, заведующий

Федеральное государственное бюджетное образовательное учреждение высшего образования «Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова» ; Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени В. А. Алмазова»

кафедра терапии факультетской с курсом эндокринологии, кардиологии с клиникой им. акад. Г. Ф. Ланга

Институт эндокринологии

НИЛ метаболического синдрома

Санкт-Петербург

Elena I. Baranova, MD, Professor, , Director, Head

Federal State Budgetary Educational Institution of Higher Education "First St. Petersburg State Medical University named after Academician I. P. Pavlov"; Federal State Budgetary Institution "National Medical Research Center named after V. A. Almazov"

Department of faculty therapy with a course of endocrinology, cardiology with a clinic named after acad. G. F. Lang

Institute of Endocrinology

NILE metabolic syndrome

Saint-Petersburg

baranova.grant2015@yandex.ruМинистерство здравоохранения Российской ФедерацииРоссияPavlov St-Petersburg State Medical UniversityRussian FederationМинистерство здравоохранения Российской ФедерацииРоссияPavlov St-Petersburg State Medical University; Almazov National Medical Research CentreRussian Federation202230032022224653Copyright © Ионин В.А., Павлова В.А., Баранова Е.И., 20222022Ионин В.А., Павлова В.А., Баранова Е.И.Ionin V.A., Pavlova V.A., Baranova E.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://persmed.elpub.ru/jour/article/view/16

   В обзоре обсуждаются актуальность проблемы синдрома обструктивного апноэ сна в реальной клинической практике, особенности диагностики и персонализированного подхода в терапии с учетом разных коморбидных состояний, рассматриваются результаты основных клинических исследований и рекомендации. Поиск литературы и отбор клинических исследований был проведен за период с 2000 по 2020 годы на сайтах Европейского и Российского обществ кардиологов, а также по базам данных PubMed, eLibrary, Google Scholar.

   The review discusses the relevance of the problem of obstructive sleep apnea syndrome in real clinical practice, features of diagnostics and a personalized approach to therapy considering various comorbid conditions, a review of the results of major clinical studies and recommendations. Literature search and selection of clinical studies was carried out for the period from 2000 to 2020 on the websites of the European and Russian Societies of Cardiology, as well as databases PubMed, eLibrary, Google Scholar.

апноэгипопноэперсонализированная терапиясердечно-сосудистые заболеванияapneacardiovascular diseaseshypopneapersonalized therapyReferencesGe L., Guyatt G., Tian J., Pan B., Chang Y., Chen Y., et al. Insomnia and risk of mortality from all-cause, cardiovascular disease, and cancer: Systematic review and meta-analysis of prospective cohort studies. Sleep Medicine Reviews 2019; 48. https://doi.org/10.1016/J.SMRV.2019.101215.Ge L., Guyatt G., Tian J., Pan B., Chang Y., Chen Y., et al. Insomnia and risk of mortality from all-cause, cardiovascular disease, and cancer: Systematic review and meta-analysis of prospective cohort studies. Sleep Medicine Reviews 2019; 48. https://doi.org/10.1016/J.SMRV.2019.101215.Kerkhof G. A. Epidemiology of sleep and sleep disorders in The Netherlands. Sleep Medicine 2017; 30: 229–39. https://doi.org/10.1016/J.SLEEP.2016.09.015.Kerkhof G. A. Epidemiology of sleep and sleep disorders in The Netherlands. Sleep Medicine 2017; 30: 229–39. https://doi.org/10.1016/J.SLEEP.2016.09.015.Qaseem A., Holty J. E. C., Owens D. K., Dallas P., Starkey M., Shekelle P. Management of obstructive sleep apnea in adults: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine 2013; 159: 471–83. https://doi.org/10.7326/0003-4819-159-7-201310010-00704.Qaseem A., Holty J. E. C., Owens D. K., Dallas P., Starkey M., Shekelle P. Management of obstructive sleep apnea in adults: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine 2013; 159: 471–83. https://doi.org/10.7326/0003-4819-159-7-201310010-00704.Myers K. A., Mrkobrada M., Simel D. L. Does this patient have obstructive sleep apnea?: The Rational Clinical Examination systematic review. JAMA 2013; 310: 731–41. https://doi.org/10.1001/JAMA.2013.276185.Myers K. A., Mrkobrada M., Simel D. L. Does this patient have obstructive sleep apnea?: The Rational Clinical Examination systematic review. JAMA 2013; 310: 731–41. https://doi.org/10.1001/JAMA.2013.276185.Kasai T., Floras J. S., Bradley T. D. Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation 2012; 126: 1495–510. https://doi.org/10.1161/CIRCULATIONAHA.111.070813.Kasai T., Floras J. S., Bradley T. D. Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation 2012; 126: 1495–510. https://doi.org/10.1161/CIRCULATIONAHA.111.070813.Gorbunova M. V., Babak S. L., Malyavin A. G. Rational antihypertensive therapy in patients with obstructive sleep apnea. The Russian Archives of Internal Medicine 2019; 9: 85–92. [Горбунова М. В. Рациональная антигипертензивная терапия пациентов с обструктивным апноэ сна / М. В. Горбунова, С. Л. Бабак, А. Г. Малявин. – Архивъ Внутренней Медицины. – 2019. – 9: 85–92. https://cyberleninka.ru/article/n/ratsionalnaya-antigipertenzivnaya-terapiya-patsientov-s-obstruktivnym-apnoe-sna?]Gorbunova M. V., Babak S. L., Malyavin A. G. Rational antihypertensive therapy in patients with obstructive sleep apnea. The Russian Archives of Internal Medicine 2019; 9: 85–92. [Горбунова М. В. Рациональная антигипертензивная терапия пациентов с обструктивным апноэ сна / М. В. Горбунова, С. Л. Бабак, А. Г. Малявин. – Архивъ Внутренней Медицины. – 2019. – 9: 85–92. https://cyberleninka.ru/article/n/ratsionalnaya-antigipertenzivnaya-terapiya-patsientov-s-obstruktivnym-apnoe-sna?]Duarte R. L. M., Magalhães-da-Silveira F. J., Gozal D. Predictive Factors for Obstructive Sleep Apnea Diagnosis in Bariatric Surgery Candidates with or Without Chronic Insomnia Complaints. Obesity Surgery 2022; 32: 33–41. https://doi.org/10.1007/S11695-021-05748-5.Duarte R. L. M., Magalhães-da-Silveira F. J., Gozal D. Predictive Factors for Obstructive Sleep Apnea Diagnosis in Bariatric Surgery Candidates with or Without Chronic Insomnia Complaints. Obesity Surgery 2022; 32: 33–41. https://doi.org/10.1007/S11695-021-05748-5.Chizhova O. Yu. The role of obstructive sleep apnea in the development of metabolic syndrome and obesity. Herald of North-Western State Medical University named after I. I. Mechnikov. 2019; 11 (2): 49–52. [Чижова О. Ю. Значение обструктивных апноэ сна в развитии метаболического синдрома и ожирения / О. Ю. Чижова // Вестник Северо-Западного государственного медицинского университета им. И. И. Мечникова. – 2019. – 11: 49–52. https://cyberleninka.ru/article/n/znachenie-obstruktivnyh-apnoe-sna-v-razvitii-metabolicheskogo-sindroma-i-ozhireniya?]Chizhova O. Yu. The role of obstructive sleep apnea in the development of metabolic syndrome and obesity. Herald of North-Western State Medical University named after I. I. Mechnikov. 2019; 11 (2): 49–52. [Чижова О. Ю. Значение обструктивных апноэ сна в развитии метаболического синдрома и ожирения / О. Ю. Чижова // Вестник Северо-Западного государственного медицинского университета им. И. И. Мечникова. – 2019. – 11: 49–52. https://cyberleninka.ru/article/n/znachenie-obstruktivnyh-apnoe-sna-v-razvitii-metabolicheskogo-sindroma-i-ozhireniya?]Arnardottir E. S., Maislin G., Schwab R. J., Staley B., Benediktsdottir B., Olafsson I., et al. The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep 2012; 35: 921–32. https://doi.org/10.5665/SLEEP.1952.Arnardottir E. S., Maislin G., Schwab R. J., Staley B., Benediktsdottir B., Olafsson I., et al. The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep 2012; 35: 921–32. https://doi.org/10.5665/SLEEP.1952.Punjabi N. M. Do sleep disorders and associated treatments impact glucose metabolism? Drugs 2009; 69 Suppl 2:13–27. https://doi.org/10.2165/11531150-000000000-00000.Punjabi N. M. Do sleep disorders and associated treatments impact glucose metabolism? Drugs 2009; 69 Suppl 2:13–27. https://doi.org/10.2165/11531150-000000000-00000.Meslier N. [Sleep apnea syndromes, metabolic syndrome and insulin resistance]. Revue Des Maladies Respiratoires 2006; 23 Spec No 2. https://doi.org/10.1016/S0761-8425(06)72487-1.Meslier N. [Sleep apnea syndromes, metabolic syndrome and insulin resistance]. Revue Des Maladies Respiratoires 2006; 23 Spec No 2. https://doi.org/10.1016/S0761-8425(06)72487-1.Barceló A., Barbé F., de La Peña M., Martinez P., Soriano J. B., Piérola J., et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008; 63: 946–50. https://doi.org/10.1136/THX.2007.093740.Barceló A., Barbé F., de La Peña M., Martinez P., Soriano J. B., Piérola J., et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008; 63: 946–50. https://doi.org/10.1136/THX.2007.093740.McNicholas W. T., Bonsignore M. R. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. The European Respiratory Journal 2007; 29: 156–78. https://doi.org/10.1183/09031936.00027406.McNicholas W. T., Bonsignore M. R. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. The European Respiratory Journal 2007; 29: 156–78. https://doi.org/10.1183/09031936.00027406.Peppard P. E., Young T., Palta M., Dempsey J., Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284: 3015–21. https://doi.org/10.1001/JAMA.284.23.3015.Peppard P. E., Young T., Palta M., Dempsey J., Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284: 3015–21. https://doi.org/10.1001/JAMA.284.23.3015.Hoyos C. M., Killick R., Keenan D. M., Baxter R. C., Veldhuis J. D., Liu P. Y. Continuous positive airway pressure increases pulsatile growth hormone secretion and circulating insulin-like growth factor-1 in a time-dependent manner in men with obstructive sleep apnea: a randomized sham-controlled study. Sleep 2014; 37: 733–41. https://doi.org/10.5665/SLEEP.3580.Hoyos C. M., Killick R., Keenan D. M., Baxter R. C., Veldhuis J. D., Liu P. Y. Continuous positive airway pressure increases pulsatile growth hormone secretion and circulating insulin-like growth factor-1 in a time-dependent manner in men with obstructive sleep apnea: a randomized sham-controlled study. Sleep 2014; 37: 733–41. https://doi.org/10.5665/SLEEP.3580.Deflandre E., Gerdom A., Lamarque C., Bertrand B. Understanding Pathophysiological Concepts Leading to Obstructive Apnea. Obesity Surgery 2018; 28: 2560–71. https://doi.org/10.1007/S11695-018-3325-6.Deflandre E., Gerdom A., Lamarque C., Bertrand B. Understanding Pathophysiological Concepts Leading to Obstructive Apnea. Obesity Surgery 2018; 28: 2560–71. https://doi.org/10.1007/S11695-018-3325-6.Blackman A., Foster G. D., Zammit G., Rosenberg R., Aronne L., Wadden T., et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. International Journal of Obesity (2005) 2016; 40: 1310–9. https://doi.org/10.1038/IJO.2016.52.Blackman A., Foster G. D., Zammit G., Rosenberg R., Aronne L., Wadden T., et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. International Journal of Obesity (2005) 2016; 40: 1310–9. https://doi.org/10.1038/IJO.2016.52.Strueva N. V., Melnichenko G. A., Poluektov M. G., Savelyeva L. V. The efficiency of obesity treatment in patients with insomnia and obstructive sleep apnea syndrome. Obesity and metabolism. 2016; 13 (2): 26–32. [Струева Н. В. Эффективность лечения ожирения у больных с инсомнией и синдромом обструктивного апноэ сна / Н. В. Струева [и др.] // Ожирение и Метаболизм. – 2015. – 13: 25–32. https://cyberleninka.ru/article/n/effektivnost-lecheniya-ozhireniya-u-bolnyh-s-insomniey-i-sindromom-obstruktivnogo-apnoe-sna?]Strueva N. V., Melnichenko G. A., Poluektov M. G., Savelyeva L. V. The efficiency of obesity treatment in patients with insomnia and obstructive sleep apnea syndrome. Obesity and metabolism. 2016; 13 (2): 26–32. [Струева Н. В. Эффективность лечения ожирения у больных с инсомнией и синдромом обструктивного апноэ сна / Н. В. Струева [и др.] // Ожирение и Метаболизм. – 2015. – 13: 25–32. https://cyberleninka.ru/article/n/effektivnost-lecheniya-ozhireniya-u-bolnyh-s-insomniey-i-sindromom-obstruktivnogo-apnoe-sna?]Burchakov D. I., Mayorov A. Yu. CPAP-THERAPY DECREASES GLYCATED HEMOGLOBIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND SLEEP APNOEA. Medical Council 2017:132–5. https://doi.org/10.21518/2079-701X-2017-10-132-135.Burchakov D. I., Mayorov A. Yu. CPAP-THERAPY DECREASES GLYCATED HEMOGLOBIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND SLEEP APNOEA. Medical Council 2017:132–5. https://doi.org/10.21518/2079-701X-2017-10-132-135.Hassaballa H. A., Tulaimat A., Herdegen J. J., Mokhlesi B. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep & Breathing = Schlaf & Atmung 2005; 9: 176–80. https://doi.org/10.1007/S11325-005-0033-Y.Hassaballa H. A., Tulaimat A., Herdegen J. J., Mokhlesi B. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep & Breathing = Schlaf & Atmung 2005; 9: 176–80. https://doi.org/10.1007/S11325-005-0033-Y.

The authors declare that there are no conflicts of interest present.